Bristol-Myers Squibb Company (BMY)

Featured here, the Income Statement (earnings report) for Bristol-Myers Squibb Company, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

68.20 +0.13 (+0.19%)

21:59:59 Closed USD Disclaimer

After-Hours 68.20 0.00 (0.00%) 22:15:04 GMT

BMY Income Statement

Total Revenue
Total Operating Expenses
Operating Income

Name	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Revenue	11,406	11,218	11,887	11,648	11,985
Revenue	11,406	11,218	11,887	11,648	11,985
Other Revenue, Total	0	0	0	0	0
Cost of Revenue, Total	2,520	2,267	2,575	2,419	2,356
Gross Profit	8,886	8,951	9,312	9,229	9,629
Total Operating Expenses	9,633	8,791	9,065	8,798	9,633
Selling/General/Admin. Expenses, Total	2,260	1,848	1,773	1,829	2,342
Research & Development	2,510	2,258	2,300	2,133	2,607
Depreciation / Amortization	2,417	2,417	-	-	-
Interest Expense (Income) - Net Operating	-233	-307	-302	-311	-311
Unusual Expense (Income)	635	146	-	-	-
Other Operating Expenses, Total	2,576	2,725	2,719	2,728	2,728
Operating Income	1,773	2,427	2,822	2,850	2,243
Interest Income (Expense), Net Non-Operating	-960	-786	-	-	-
Gain (Loss) on Sale of Assets	166	-11	-254	-383	-486
Other, Net	-252	229	1,118	1,546	980
Net Income Before Taxes	1,859	2,209	1,958	1,687	1,858
Provision for Income Taxes	-166	601	529	404	-514
Net Income After Taxes	2,025	1,608	1,429	1,283	2,372
Minority Interest	57	63	61	65	0
Equity In Affiliates	-	-	-	-	-
U.S GAAP Adjustment	-	-	-	-	-
Net Income Before Extraordinary Items	2,022	1,606	1,421	1,278	2,372
Total Extraordinary Items	0	0	0	0	0
Net Income	2,022	1,606	1,421	1,278	2,372
Total Adjustments to Net Income	0	0	0	0	-
Income Available to Common Excluding Extraordinary Items	2,022	1,606	1,421	1,278	2,372
Dilution Adjustment	-0.70	-5	2.66	1.24	-
Diluted Net Income	2,022.70	1,611	1,418.34	1,276.76	2,372
Diluted Weighted Average Shares	2,124	2,148	2,149	2,164	2,221
Diluted EPS Excluding Extraordinary Items	0.95	0.75	0.66	0.59	1.08
DPS - Common Stock Primary Issue	0.57	0.54	0.54	0.54	0.49
Diluted Normalized EPS	0.57	0.82	0.86	0.85	0.73

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.